The β2-Adrenergic modulator celiprolol reduces insulin resistance in obese zucker rats
- 23 April 1999
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 64 (22) , 2071-2079
- https://doi.org/10.1016/s0024-3205(99)00154-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Antihypertensive therapy and insulin sensitivity: Do we have to redefine the role of β-blocking agents?American Journal of Hypertension, 1998
- Insulin Sensitivity in a Long-Term Crossover Trial with Celiprolol and Other Antihypertensive AgentsJournal of Cardiovascular Pharmacology, 1998
- Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDMDiabetes, 1997
- The Antioxidant α-Lipoic Acid Enhances Insulin-Stimulated Glucose Metabolism in Insulin-Resistant Rat Skeletal MuscleDiabetes, 1996
- Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivityJournal Of Hypertension, 1996
- Treatment with a β-blocker with β2-agonism improves glucose and lipid metabolism in essential hypertensionMetabolism, 1994
- Metabolic Effects of Pindolol and Propranolol in a Double-Blind Cross-Over Study in Hypertensive PatientsBlood Pressure, 1992
- Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibitionJournal of Diabetic Complications, 1990
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.BMJ, 1989